# Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study

> **NCT02219373** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Pediatric Chronic Neuropathic Pain

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Oxcarbazepine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02219373
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02219373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02219373, "Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02219373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*